ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
1.160
+0.010 (0.87%)
At close: Sep 18, 2026, 4:00 PM EDT
1.140
-0.020 (-1.72%)
After-hours: Sep 18, 2026, 7:30 PM EDT
ABVC BioPharma Employees
As of December 31, 2025, ABVC BioPharma had 19 total employees, including 16 full-time and 3 part-time employees. The number of employees did not change compared to the previous year.
Employees
19
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$374,033
Market Cap
30.07M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 19 | 0 | - | 16 | 3 |
| Dec 31, 2024 | 19 | 0 | - | 16 | 3 |
| Dec 31, 2023 | 19 | -4 | -17.39% | 16 | 3 |
| Dec 31, 2022 | 23 | -7 | -23.33% | 19 | 4 |
| Dec 31, 2021 | 30 | -4 | -11.76% | 28 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Aligos Therapeutics | 82 |
| IGC Pharma | 70 |
| Evaxion | 46 |
| BeyondSpring | 44 |
| NextCure | 40 |
| Quince Therapeutics | 38 |
| Kyntra Bio | 34 |
| Quantum BioPharma | 17 |
ABVC News
- 8 days ago - ABVC BioPharma Proxy statement: Proxy filing - Filings
- 25 days ago - ABVC BioPharma Proxy statement: Proxy filing - Filings
- 5 weeks ago - ABVC BioPharma Proxy statement: Proxy filing - Filings
- 5 weeks ago - ABVC BioPharma Quarterly report: Q2 2026 - Filings
- 6 weeks ago - ABVC Biopharma Inc trading halted, news pending - TheFly
- 7 weeks ago - ABVC BioPharma Proxy statement: Proxy filing - Filings
- 4 months ago - ABVC BioPharma Quarterly report: Q1 2026 - Filings
- 6 months ago - ABVC BioPharma Proxy statement: Proxy Filing - Filings